$TXN

Texas Instruments Stocks Rise Higher, Setting $6.05 Billion Midpoint After Broad Recovery

Texas Instruments (TXN) shares rose 0.72% to $281.52 on October 23, with a December-quarter revenue midpoint of $6.05 billion, similar to September. Q3 revenue increased 11% sequentially and 28% year-over-year, with growth in industrial, automotive, and data-center applications. The company expects Q4 revenue of $5.8B-$6.3B and earnings of $2.45-$2.79 per share. Capital expenditures over the past year totaled $2.6 billion.

Original reporting
Published Oct 23, 2026, 5:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 5:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Texas Instruments Stocks Rise Higher, Setting $6.05 Billion Midpoint After Broad Recovery — source image
Decision brief

The 30-second read

$TXNNeutralHigh
01

Why it matters

The guidance may lead to modest price pressure as expectations for continued growth are tempered.

02

Market read

Earnings and guidance for a large‑cap semiconductor firm, directly affecting its stock and sector peers.

03

What to watch

Capital expenditure of $2.6 billion may support future margin expansion despite short‑term revenue plateau.

Relevance 8/10Novelty 8/10Timing: today

Background

Texas Instruments posted strong Q3 earnings but signaled a pause in sequential sales growth with flat Q4 revenue guidance.

Company-level read

Ticker impact

$TXNNeutralHigh confidence
Context

TXN reported Q3 operating profit of $2.874 billion and gave Q4 revenue guidance of $5.8‑$6.3 billion, essentially flat versus the prior midpoint.

Expected impact

potential slight downside as market prices in flat guidance

Evidence & confidence

The guidance range is near the previous midpoint, suggesting limited growth and may cause investors to trim positions.

Market effects

May signal a slowdown in the analog and embedded chip sector, prompting peers to be re‑evaluated.

US semiconductor stocks could see modest pressure in the near term.

Limited, as the news is company‑specific to a large‑cap US chipmaker.

Counterpoint

Investors could view the flat guidance as a sign of disciplined capital allocation and hold the stock for long‑term upside.

Key entities

  • Texas Instruments

    Analog and embedded chipmaker (NASDAQ:TXN).

Related articles

$METAHighAI 8/10

Dow and Small Caps Climb Weekly While Nasdaq Slips on Megacap Earnings Charges

Stocks ended the week mixed: Dow +0.64%, Russell 2000 +2.07%, Nasdaq -0.45%, S&P 500 -0.22%. Meta (META) reported $64.6B revenue, $9.86B net income with a $9.89B litigation charge. Texas Instruments (TXN) posted $6.06B revenue, $2.43B net income. RTX (RTX) saw $25B sales, $2.26 adjusted EPS. IBM (IBM) reported $17.1B revenue, $2.31 GAAP EPS. First Citizens (FCNCA) net income fell to $606M.

$TXNHighAI 9/10

Key facts: TXN Q3 $6.06B; Q4 $5.8–6.3B; Fab Ramp; Stock ≈ $281.23

Texas Instruments (TXN) reported Q3 revenue of $6.06B, GAAP EPS of $2.62, and net income of $2.43B. Q4 guidance is $5.8B–$6.3B revenue and $2.45–$2.79 EPS. The company is expanding production capacity, with new facilities in Sherman and Lehi, and a larger site in Malaysia. TXN stock trades around $281.23, 17% above its GF Value.

$TXNMedAI 8/10

Texas Instruments Stocks Slip Despite Broad Chip Recovery

Texas Instruments reported Q3 revenue of $6.06B and EPS of $2.62, with shares down 1.20% on Oct 22. Sales grew 28% YoY and 11% QoQ, driven by industrial, automotive, and data-center sectors. Management forecasts Q4 revenue between $5.80B-$6.30B and EPS between $2.45-$2.79. Shares trade 17.07% above GF Value estimate.